Government
When the pandemic hit, many companies diverted resources aimed at HIV to COVID-19, which ended up pausing some research efforts.
Ocugen submitted a “Master File” to the U.S. FDA for COVAXIN, the vaccine that has already received authorization in India for people ages 12 and above.
The UK’s Competition and Markets Authority (CMA) will determine if the deal is anti-competitive.
The White House has also called for an independent investigation and more information from China about the pandemic’s origins.
The disclosure comes the day before the WHO is expected to plan for the next phase of investigations into the origins of COVID-19.
The House Select Subcommittee on the Coronavirus Crisis questioned executives from Emergent BioSolutions as part of a congressional probe.
House Oversight and Reform Committee slammed AbbVie for price increases on its drugs Humira Imbruvica. It said the company profited from patients and taxpayers.
FDA says it is possible booster shots would be necessary for fully vaccinated individuals within a year even though vaccines are highly effective at COVID-19 prevention.
The high court’s decision will prevent Sandoz from launching its biosimilar to Amgen’s blockbuster rheumatoid arthritis drug.
New pandemic guidelines from the CDC nearly eliminates mask-wearing requirement for fully vaccinated people.
PRESS RELEASES